Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yayon

Showing results (61-70 of 146) with videos related to

Pageof 15
Sort By:
Clinical Orthopaedics and Related Research|November 5, 1999
Fibroblast growth factor receptor-3 as a marker for precartilaginous stem cellsD Robinson, A Hasharoni, N Cohen, et al.
The EMBO Journal|May 1, 1992
A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin foldA Yayon, Y Zimmer, G H Shen, et al.
Physical Review Letters|October 13, 2007
Observing spin polarization of individual magnetic adatomsY Yayon, V W Brar, L Senapati, et al.
Acta Crystallographica. Section D, Biological Crystallography|February 27, 2001
Structure of fibroblast growth factor 9 shows a symmetric dimer with unique receptor- and heparin-binding interfacesH J Hecht, R Adar, B Hofmann, et al.
Journal of Neurochemistry|June 20, 2001
Basic fibroblast growth factor: a potential inhibitor of glutamine synthetase expression in injured neural tissueY Kruchkova, I Ben-Dror, A Herschkovitz, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 29, 2005
FGF upregulates osteopontin in epiphyseal growth plate chondrocytes: implications for endochondral ossificationS Weizmann, A Tong, A Reich, et al.
Experimental Cell Research|June 20, 1998
Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2W Roeckl, D Hecht, H Sztajer, et al.
Biochemistry|September 13, 1994
Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesisL Y Li, M Safran, D Aviezer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 1996
Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1E Levi, R Fridman, H Q Miao, et al.
European Journal of Radiology|April 5, 2011
Assessment of cartilage repair after chondrocyte transplantation with a fibrin-hyaluronan matrix--correlation of morphological MRI, biochemical T2 mapping and clinical outcomeIris Eshed, Siegfried Trattnig, Michal Sharon, et al.
Pageof 15

Showing results (61-70 of 146) with videos related to

Sort By:
Pageof 15
Clinical Orthopaedics and Related Research|November 5, 1999
Fibroblast growth factor receptor-3 as a marker for precartilaginous stem cellsD Robinson, A Hasharoni, N Cohen, et al.
The EMBO Journal|May 1, 1992
A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin foldA Yayon, Y Zimmer, G H Shen, et al.
Physical Review Letters|October 13, 2007
Observing spin polarization of individual magnetic adatomsY Yayon, V W Brar, L Senapati, et al.
Acta Crystallographica. Section D, Biological Crystallography|February 27, 2001
Structure of fibroblast growth factor 9 shows a symmetric dimer with unique receptor- and heparin-binding interfacesH J Hecht, R Adar, B Hofmann, et al.
Journal of Neurochemistry|June 20, 2001
Basic fibroblast growth factor: a potential inhibitor of glutamine synthetase expression in injured neural tissueY Kruchkova, I Ben-Dror, A Herschkovitz, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|October 29, 2005
FGF upregulates osteopontin in epiphyseal growth plate chondrocytes: implications for endochondral ossificationS Weizmann, A Tong, A Reich, et al.
Experimental Cell Research|June 20, 1998
Differential binding characteristics and cellular inhibition by soluble VEGF receptors 1 and 2W Roeckl, D Hecht, H Sztajer, et al.
Biochemistry|September 13, 1994
Diminished heparin binding of a basic fibroblast growth factor mutant is associated with reduced receptor binding, mitogenesis, plasminogen activator induction, and in vitro angiogenesisL Y Li, M Safran, D Aviezer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 9, 1996
Matrix metalloproteinase 2 releases active soluble ectodomain of fibroblast growth factor receptor 1E Levi, R Fridman, H Q Miao, et al.
European Journal of Radiology|April 5, 2011
Assessment of cartilage repair after chondrocyte transplantation with a fibrin-hyaluronan matrix--correlation of morphological MRI, biochemical T2 mapping and clinical outcomeIris Eshed, Siegfried Trattnig, Michal Sharon, et al.
Pageof 15